Episode Details
Back to Episodes
Moderna’s Melanoma Vaccine Breakthrough | Miami News
Published 1 week ago
Description
Moderna’s breakthrough melanoma vaccine is rewriting the rules of cancer treatment—using AI to craft a personalized shot from your own tumor, combined with Merck’s Keytruda, it’s slashing recurrence rates in advanced cases. Phase Three results are explosive: patients stayed cancer-free longer, and Moderna’s stock jumped over 100%. This isn’t sci-fi—it’s the future of mRNA therapy, poised for FDA review.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/113ee71ebc1490f0